date,title,source
Nov-01-18,Sierra Oncology to Report Clinical Data at ASH 2018 from Translational Biology Study of Momelotinib in Transfusion Dependent Patients,PR Newswire
Nov-07-18,Sierra Oncology to Present at the Jefferies 2018 London Healthcare Conference,CNW Group
Nov-08-18,Sierra Oncology Reports Third Quarter Results,CNW Group
Nov-13-18,Sierra Oncology Reports SRA141 Preclinical Efficacy at EORTC-NCI-AACR Symposium,CNW Group
Nov-15-18,Sierra Oncology Reports Preclinical Efficacy for Chk1 inhibitor SRA737 in Treatment Refractory Ovarian Cancer Models at the EORTC-NCI-AACR Symposium,PR Newswire
Nov-27-18,Sierra Oncology to Host Analyst Call Highlighting Clinical Data on Momelotinib's Anemia Benefit,CNW Group
Nov-29-18,Sierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737,CNW Group
